Shares outstanding increased 41.0%
Shares outstanding changed +41.0% from the comparable as-filed period. The change ranks at the 88th percentile of 8 prior comparable changes.
Ranked by interpretable importance, issuer history, magnitude, and accounting profile. No directional recommendation.
Shares outstanding changed +41.0% from the comparable as-filed period. The change ranks at the 88th percentile of 8 prior comparable changes.
Capital expenditure changed -100.0% from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes.
Operating income changed +52.0% from the comparable as-filed period.
Research & development changed -37.4% from the comparable as-filed period.
Current liabilities changed +81.9% from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes.
Stock-based compensation changed -46.9% from the comparable as-filed period.
Working capital / assets changed +1301 basis points from the comparable as-filed period. The change ranks at the 0th percentile of 4 prior comparable changes. This reverses 4 consecutive comparable moves in the opposite direction.
Method Importance combines metric-family relevance, magnitude, issuer-history unusualness, persistence, and financial-statement significance. It is analytical prioritization, not a legal materiality conclusion or investment signal.